← SynDRA
BAY 60-4552
SynDRA canonical compound SYN1958757 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | GUCY1A1 |
|---|
| Mechanism of action | guanylate cyclase stimulant |
|---|
All known targets
Mechanisms of action (all sources)
- guanylate cyclase stimulant
Cross-references
Synonyms
- Nelociguat
- UNII-M2A18LL56O
- Methyl (4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)pyrimidin-5-yl)carbamate
- BAY60-4552
- M2A18LL56O
- Methyl [4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl]carbamate
- methyl N-[4,6-diamino-2-[1-[(2-fluorophenyl)methyl]pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl]carbamate
- Carbamic acid, N-(4,6-diamino-2-(1-((2-fluorophenyl)methyl)-1H-pyrazolo(3,4-b)pyridin-3-yl)-5-pyrimidinyl)-, methyl ester
- Nelociguat [INN]
Look up BAY 60-4552 in the interactive SynDRA portal →